S. 272: Protect Infant Formula from Contamination Act
Sponsor
Gary Peters
Democrat · MI
Bill Progress
Latest Action · Jan 28, 2026
Placed on Senate floor schedule under General Orders. Calendar No. 306.
Why it matters
The bill puts both formula makers and the FDA on a 1-business-day clock when contamination is found. It also requires quarterly supply-chain reports for 5 years, so Congress can track whether safer formula is actually staying on shelves.
S. 272 speeds up the first response when infant formula may be contaminated or mislabeled. A manufacturer that learns a formula may be unsafe would have 1 business day to notify the government. If a finished formula sample gets a confirmed positive result for a microorganism covered by federal testing rules, the company would also have to report that within 1 business day, even if the product has already left the facility.
The FDA would be on the same short clock. Within 1 business day of getting that notice, the agency would have to respond and start discussions about the investigation and corrective action. Within 90 days, the agency would have to confirm the company is doing an appropriate investigation and response, using documentation from the manufacturer.
The bill also reaches beyond contamination response. It requires a progress report within 180 days on the FDA's infant formula market resiliency strategy, then supply-chain reports no less than quarterly starting within 270 days and continuing for 5 years. Additional reports at 1 year, 3 years, and 5 years would examine what practices could improve both formula safety and supply.
What does S. 272 do?
Companies must report contamination within 1 business day
If a formula maker learns a product may be adulterated or mislabeled, it must notify the Secretary within 1 business day instead of reporting on an open-ended timeline.
Positive microorganism tests trigger immediate notice
A confirmed positive test in finished infant formula for a microorganism covered by federal testing rules must be reported within 1 business day, even if the product has already left the manufacturer's control.
FDA has 1 business day to respond
After receiving a notice, the Secretary must respond within 1 business day to begin discussions about the investigation and corrective action.
Manufacturers may have to stop distribution
After a confirmed positive result, a company must consult with the Secretary about isolating the affected product and, if required, stop distribution and properly dispose of it.
FDA gets 90 days to verify the investigation
Within 90 days of a contamination notice, the Secretary must confirm through documentation that the manufacturer performed, or is performing, an appropriate investigation and corrective action.
Formula supply gets quarterly oversight for 5 years
The bill requires a progress report within 180 days, supply-chain reports starting within 270 days and continuing at least quarterly for 5 years, plus broader supply-adequacy reviews at 1 year, 3 years, and 5 years.
Who benefits from S. 272?
Parents feeding babies formula
You would get a faster response system when contamination is suspected, with both manufacturers and FDA operating on a 1-business-day deadline.
Infants who rely on formula
The bill is designed to shorten the time between a confirmed contamination problem and the actions needed to isolate product, stop distribution, and review what went wrong.
Families hit by formula shortages
You could benefit from longer-term oversight of supply, since the bill requires quarterly reports for 5 years and additional reviews on whether formula availability is actually adequate.
Congress overseeing formula safety
Lawmakers would get recurring reports on in-stock rates, supply conditions, and the FDA's progress carrying out its market resiliency strategy.
Who is affected by S. 272?
Infant formula manufacturers
They would face faster reporting deadlines, more documentation demands, and potential orders to isolate, stop distributing, or dispose of affected formula.
FDA and HHS officials
They would have new response deadlines: 1 business day to engage after a contamination notice, 90 days to confirm the company's investigation, and multiple reporting obligations over 5 years.
Testing labs and quality-control teams
Their testing methods and handling practices could receive closer review, because the bill tells the Secretary to consider laboratory methods and possible cross-contamination during testing.
USDA and other federal agencies
They would be pulled into ongoing coordination about immediate formula needs and long-term market resiliency.
What Congress Is Saying
S. 272 hasn't been debated on the floor yet.
This section updates when a legislator speaks about it on the floor or in committee.
S272 Legislative Journey
Committee Action
Jan 28, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Passed Committee
Jan 15, 2026
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee Action
Jan 28, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
About the Sponsor
Gary Peters
Democrat, MI · 17 years in Congress
Committees: Homeland Security and Governmental Affairs, Commerce, Science, and Transportation, Armed Services
View full profile →
Cosponsors (9)
This bill has 9 cosponsors: 6 Democrats, 3 Republicans, reflecting bipartisan support. Cosponsors represent 8 states: Maine, Minnesota, North Dakota, and 5 more.
Committee Sponsors
Health, Education, Labor, and Pensions Committee
5 of 22 committee members cosponsored
6 Democrats across this committee haven't cosponsored yet. Mobilize their constituents
S. 272 Quick Facts
- Committee
- Health, Education, Labor, and Pensions
- Chamber
- Senate
- Policy
- Health
- Introduced
- Jan 28, 2025
Placed on Senate floor schedule under General Orders. Calendar No. 306.
Jan 28, 2026
Official Sources
Official bill page with status, text, sponsors, and legislative actions for the Protect Infant Formula from Contamination Act.
This regulation is directly cited in the bill for required finished-product testing of infant formula for microorganisms.
The bill amends section 412 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. 350a, which governs infant formula.
The bill's contamination reporting and corrective-action requirements fit within FDA's broader food safety oversight and prevention framework.
This FDA resource explains how the agency communicates food safety problems and recalls, which is relevant when contaminated formula must be isolated or removed from distribution.
S. 272 Common Questions
How fast would formula companies have to report contamination under S. 272?
Within 1 business day. If a manufacturer learns a formula may be contaminated or mislabeled, S. 272 says it must notify the government on that timeline.
Does S. 272 apply if the formula already shipped?
Yes. The bill says a confirmed positive microorganism test still has to be reported within 1 business day even if the formula has already left the manufacturer's control.
How quickly would FDA have to respond to a formula contamination report?
Also within 1 business day. S. 272 requires the Secretary to respond and begin discussions about the investigation and corrective action right away.
Could the government make a company stop selling affected formula?
Yes. After a confirmed positive result, the manufacturer must consult with the Secretary and may be required to isolate the product, stop distribution, and dispose of it.
How long would FDA have to verify the company's investigation?
90 days. The bill says the Secretary must confirm through documentation that the manufacturer performed, or is performing, an appropriate investigation and corrective action.
Would S. 272 require companies to share lab results or genetic sequencing?
Yes. The bill says manufacturers must provide results and isolates from a positive sample, or the whole genetic sequence from a confirmed positive analytical result.
Does S. 272 do anything about formula shortages?
Yes. It requires a progress report within 180 days, then supply-chain reports starting within 270 days and continuing at least quarterly for 5 years.
Would S. 272 create new long-term reviews of formula supply?
Yes. The bill requires additional reports at 1 year, 3 years, and 5 years on whether formula supply is adequate and what practices could improve safety and availability.
Based on S. 272 bill text
S. 272 Bill Text
“To improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements, and for other purposes.”
Source: U.S. Government Publishing Office
Get notified when S. 272 moves
Committee votes, floor action, cosponsor changes — straight to your inbox.
Bill alerts + Legisletter's monthly briefing. Unsubscribe anytime.
Health Bills
9 related bills we're tracking
Give Kids a Chance Act of 2025
Motion to reconsider laid on the table Agreed to without objection.
Dec 1, 2025
Improving Seniors’ Timely Access to Care Act of 2025
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 20, 2025
CONNECT for Health Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 26, 2025
Right to Contraception Act
Referred to the House Committee on Energy and Commerce.
Feb 5, 2025
Medicare Patient Access and Practice Stabilization Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 31, 2025
Chiropractic Medicare Coverage Modernization Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 16, 2025
988 LGBTQ+ Youth Access Act of 2025
Referred to the House Committee on Energy and Commerce.
Sep 17, 2025
Ensuring Lasting Smiles Act
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 8, 2025
Pride In Mental Health Act of 2025
Referred to the House Committee on Energy and Commerce.
Jun 5, 2025
Trending Right Now
Bills gaining momentum across Congress
Congressional Tribute to Constance Baker Motley Act of 2025
Referred to the House Committee on Financial Services.
Sep 11, 2025
Deterring American AI Model Theft Act of 2026
Referred to the House Committee on Foreign Affairs.
Apr 15, 2026
GUARDRAILS Act
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Mar 26, 2026
Tracking Health in Congress? Monitor bills, track cosponsor momentum, and launch advocacy campaigns — all from one advocacy platform.